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Propionibacterium acnes is the most abundant bacterium on human skin, particularly in sebaceous areas. P. acnes is suggested
to be an opportunistic pathogen involved in the development of diverse medical conditions but is also a proven contaminant of
human clinical samples and surgical wounds. Its significance as a pathogen is consequently a matter of debate. In the present
study, we investigated the presence of P. acnesDNA in 250 next-generation sequencing data sets generated from 180 samples of
20 different sample types, mostly of cancerous origin. The samples were subjected to either microbial enrichment, involving nu-
clease treatment to reduce the amount of host nucleic acids, or shotgun sequencing. We detected high proportions of P. acnes
DNA in enriched samples, particularly skin tissue-derived and other tissue samples, with the levels being higher in enriched
samples than in shotgun-sequenced samples. P. acnes reads were detected in most samples analyzed, though the proportions in
most shotgun-sequenced samples were low. Our results show that P. acnes can be detected in practically all sample types when
molecular methods, such as next-generation sequencing, are employed. The possibility of contamination from the patient or
other sources, including laboratory reagents or environment, should therefore always be considered carefully when P. acnes is
detected in clinical samples. We advocate that detection of P. acnes always be accompanied by experiments validating the associ-
ation between this bacterium and any clinical condition.
Propionibacterium acnes is a facultative anaerobic Gram-posi-tive bacterium present on human skin as part of the normal
flora, as well as in the oral cavity, large intestine, conjunctiva, and
external ear canal (1). P. acnes is the most prevalent bacterium in
sebaceous areas of the skin (2, 3) but is also abundant in dry
areas (3). P. acnes predominates in the pilosebaceous follicles of
the skin (4).
P. acnes is proposed to play a role in the development of acne
vulgaris (5) and is considered an opportunistic pathogen causing
postoperative infections (6). It has been isolated from patients
with endocarditis (7), synovitis, acne, pustulosis, hyperostosis,
and osteitis (SAPHO) syndrome (8), and sarcoidosis (9), among
other syndromes. Some studies also identify P. acnes to be a con-
taminant of blood products, tissue cultures, and surgical wounds
(10–13), and the significance of this widely abundant skin com-
mensal is consequently debated.
The postulated role of P. acnes in various conditions is often
highly speculative and based on the mere detection of the bacte-
rium (8, 9, 14–19). To expand the knowledge of the abundance of
P. acnes, we investigated the proportions of P. acnes sequences in
samples of a wide variety of cancer types, as well as blood samples.
Next-generation sequencing was performed on DNA extracted
either after enrichment for intact microbes or directly from the
samples. This study is the first large-scale analysis investigating the
abundance of P. acnes DNA in such diverse tissue types by next-
generation sequencing, and we show that P. acnes can be readily
detected in literally all sample types investigated, particularly
when samples are subjected to microbial enrichment.
MATERIALS AND METHODS
Ethics statement.Human sample collection, handling, and analysis were
performed under ethical protocol H-2-2012-FSP2 (Regional Committee
on Health Research Ethics, Capital Region of Denmark) and case no.
1304226 (National Committee on Health Research Ethics, Denmark). In
accordance with Danish national legislation (Sundhedsloven), all human
samples were processed anonymously.
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Patient samples. (i) Samples collected in Denmark. Malignant mel-
anoma biopsy specimens and cells from patients with acute myeloid leu-
kemia (AML), B-cell chronic lymphocytic leukemia (B-CLL), and chronic
myelogenous leukemia (CML) sorted by fluorescence-activated cell sort-
ing (FACS) were obtained from Aarhus University Hospital. Samples
from patients with T-lineage acute lymphoblastic leukemia (T-ALL) were
obtained from either Aarhus University Hospital (cells sorted by FACS;
n 9) or Rigshospitalet (Copenhagen University Hospital; bone marrow
samples; n  2). Samples (bone marrow) from patients with B-cell pre-
cursor acute lymphoblastic leukemia (BCP-ALL) and biopsy specimens
from patients with oropharyngeal or oral cavity head and neck cancer and
testicular cancer were obtained from Rigshospitalet. Biopsy specimens
frompatientswith basal cell carcinoma andmycosis fungoides (cutaneous
T-cell lymphoma) were obtained from Bispebjerg Hospital. Bladder,
breast, and colon cancer biopsy specimens, blood samples from colon
cancer patients, and ascitic fluid samples from colon, ovarian, and pan-
creatic cancer patients were obtained from or collected in collaboration
with the Danish Cancer Biobank, Herlev Hospital. Ascitic fluid samples
were subjected to low-speed centrifugation upon receipt to pellet intact
host cells and cellular debris. The supernatant was used for microbial
enrichment, whereas pelleted cells were used for shotgun sequencing.
Cryopreserved, fully transformed B-cell lymphoma cell lines (OCI
Ly3_M, OCI-Ly7_M, OCI-Ly8, SU-DHL-4, SU-DHL-5, and U698M)
and multiple myeloma cell lines (KMS-12-BM, KMS-12-PE, MOLP-2,
MOLP-8, RPMI-8226, andU266) were obtained fromAalborgUniversity
Hospital.
(ii) Samples collected outside Denmark. Vulva cancer biopsy speci-
mens were obtained from the National Institute of Oncology, Budapest,
Hungary. All samples are listed in Table 1.
Laboratory facilities. All sample processing was performed under
conditions designed to diminish contamination through the use of a uni-
directional work flow. Separate laboratories were used for reagent prepa-
ration, sample extraction and sequencing library preparation, and library
amplification. All laboratory work was conducted by individuals who
were wearing a lab coat and gloves, as well as sleeves during extraction and
library preparation. All sample processingwas carried out in laminar-flow
cabinets equipped with UV lamps. All benchtops were cleaned with 5%
bleach and 70% ethanol before and after any lab work. Only sterile, dis-
posable lab utensils were used. Filter tips were used for all pipetting.
Microbial enrichment, nucleic acid extraction, and library prepara-
tion. Samples used for enrichment were fresh frozen after collection, and
no nucleic acid preservatives were added. Each batch of processed samples
included a nontemplate control containing only phosphate-buffered sa-
line (PBS), which was run in parallel with the patient samples (n  19).
Samples were kept on ice unless otherwise stated.
Biopsy specimenswere thawed and transferred to 400l cold PBS. For
the samples from leukemia patients, 150 to 400 l was mixed with cold
PBS to a total volume of 400 l. Two stainless steel beads of 2 to 3 mm in
diameter were added to the samples, which were subsequently homoge-
nized using a TissueLyser II tissue disrupter (Qiagen, Hilden, Germany)
for 6 min at 30 Hz. All tissue homogenates, samples from leukemia pa-
tients, and ascitic fluid specimens (1 ml) devoid of pelleted cells were
centrifuged for 2 min at 800  g to remove tissue debris, and the super-
natants were subsequently filtered through 5-m-pore-size centrifuge fil-
ters (Millipore, Darmstadt, Germany). To remove unprotected nucleic
acids while retaining the nucleic acids within bacterial cells or viral parti-
cles, the filtrates were nuclease digested using 14l TurboDNase (2 U/l;
Ambion, Thermo Fisher Scientific, Waltham, MA, USA), 12 l Baseline-
ZeroDNase (1U/l; Epicentre,Madison,WI, USA), 16l RNase cocktail
enzyme mix (Ambion), and 40 l 10 Turbo DNase buffer in a total
volume of 400 l and incubated at 37°C for 2 h. Nucleic acids from the
enriched samples were extracted using the High Pure viral RNA kit
(Roche, Basel, Switzerland) according to the manufacturer’s instructions
with the addition of 10 g linear acrylamide carrier (Applied Biosystems,
Foster City, CA, USA).
DNA libraries were built using the Nextera or Nextera XT DNA sam-
ple preparation kit (Illumina, San Diego, CA, USA), according to the
manufacturer’s instructions. Nextera libraries were amplified by 20 cy-
cles of PCR, and Nextera XT libraries were amplified by 12 cycles of
PCR. The amplified and indexed libraries were purified using the
TABLE 1 Samples included in the studya
Disease Abbreviation Sample type
No. of samples subjected to:
Microbial
enrichment
Shotgun
sequencing
Acute myeloid leukemia AML Bone marrow (sorted cells) 9
B-cell chronic lymphocytic leukemia B-CLL Blood/bone marrow (sorted cells) 9
B-cell precursor acute lymphoblastic leukemia BCP-ALL Bone marrow 8
Basal cell carcinoma BCC Tumor biopsy specimens 11 11
Bladder cancer Tumor biopsy specimens 7
Breast cancer (ductal/lobular) Tumor biopsy specimens 17 20
Ascitic fluid 1 1
Chronic myelogenous leukemia CML Bone marrow (sorted cells) 10
Colon cancer Tumor biopsy specimens 3 12
Blood 8
Ascitic fluid 1
Lymphoma/myeloma Cell lines 12
Malignant melanoma Tumor biopsy specimens 10 10
Mycosis fungoides (cutaneous T-cell lymphoma) Mycosis Tumor biopsy specimens 11 11
Oropharyngeal/oral cavity cancer Oral Tumor biopsy specimens 10 9
Ovarian cancer Ascitic fluid 3 5
Pancreatic cancer Ascitic fluid 2
T-lineage acute lymphoblastic leukemia T-ALL Bone marrow (nonsorted/sorted cells) 11
Testicular cancer (sem/non-sem) Testis Tumor biopsy specimens 20 5
Vulva cancer Vulva Tumor biopsy specimens 3
Total no. of sample types and samples 20 143 107
a The diseases, sample types, and number of samples included are shown.
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Agencourt AMPure XP PCR purification system (Beckman Coulter,
Indianapolis, IN, USA). In case of insufficient amplification, libraries
were reamplified using AccuPrime Pfx DNA polymerase (Life Technolo-
gies, Carlsbad, CA, USA) and P5 and P7 sequence primers.
Total DNA extraction and library preparation. Total DNA was ex-
tracted from samples using theQIAampDNAminikit (Qiagen) following
the manufacturer’s instructions. DNA libraries were prepared from 1 g
of DNA using either the TruSeq DNA protocol (catalog number PE-940-
2001; Illumina, San Diego, CA, USA) or an in-house protocol (20) using
NEBnext reagents (protocol E6070; New England BioLabs, Ipswich, MA,
USA).
Sequencing. Paired-end sequencing (2 reads of 100 bp) was per-
formed on the Illumina HiSeq 2000 platform at BGI-Europe (Copenha-
gen N, Denmark).
Analysis of sequencedata. (i)Preprocessinganddepletionofhuman
sequence reads. Paired-end sequencing reads were trimmed of adapter
sequences, and overlapping read pairs were merged using Adapter-
Removal software (version 1.5.3) (21). Reads shorter than 30 nucleotides
after trimming were excluded from further analysis. For digital subtrac-
tion of human sequence reads, the remaining reads were mapped to the
human genome (hg38) using the mem algorithm implemented in Bur-
rows-Wheeler Aligner (BWA; version 0.7.7) (22). Reads of a pair were
evaluated independently. Reads containing 25 bp or more of low-com-
plexity regions were filtered out using the DustMasker algorithm (version
1.0.0) (23).
(ii) Analysis of reads mapping to P. acnes. Genomic sequences from
97 P. acnes strains representing complete genomes, scaffolds, or contigs
were downloaded from theNCBI genome resource (http://www.ncbi.nlm
.nih.gov/genome/genomes/1140) (see Table S1 in the supplemental ma-
terial). Reads filtered of human and low-complexity sequences were
mapped to the P. acnes sequences using the aln algorithm in BWA (22)
after duplicate reads had been marked using the SAMBLASTER program
(24). Only reads with a perfect match were kept for further analysis. The
proportion of P. acnes reads was calculated as the number (parts per mil-
lion) of unique P. acnes reads relative to the total number of demulti-
plexed reads.
(iii) Analysis of the P. acnes strains present. The presence of the
different P. acnes strains was assessed on the basis of themapping to the P.
acnes genomic sequences (above).Only readsmapping exclusively to a single
strain were considered for this analysis. Information regarding the phyloge-
netic type of the different strains was obtained from the P. acnes multilocus
sequence typing (MLST) database (http://pubmlst.org/pacnes/).
(iv) Analysis of the coverage of the P. acnes genome. To visualize the
genomic coverage of P. acnes, all nonhuman reads were mapped to the 12
full P. acnes genomes currently present in GenBank using the mem algo-
rithm implemented in BWA (version 0.7.7) (22). The resulting align-
ments are represented as Circos plots (25).
Nucleotide sequence accession numbers. Sequencing readsmapping
to P. acnes have been uploaded to the European Nucleotide Archive
(ENA) and are available under accession number PRJEB12636.
RESULTS
P. acnes in microbe-enriched and shotgun-sequenced samples.
The relative number ofP. acnes sequencing reads in 180 samples of
20 different sample types was analyzed (Table 1). Ascitic fluid
samples and lymphoma/myeloma cell lines were analyzed as each
being one common sample category. One hundred forty-three
samples were processed to enrich for intact microbes before ex-
traction of DNA and preparation of sequencing libraries. Se-
quencing reads from which human reads were removed were
mapped to a custom database containing the 97 P. acnes genomes
currently present in GenBank as full genomes or genome assem-
blies. P. acnes levels were assessed as the number (parts per mil-
lion) of unique P. acnes reads relative to the total number of de-
multiplexed reads (see Materials and Methods). Using this
approach, we detected relative levels of P. acnes reads exceeding
300 ppm in samples from patients with basal cell carcinoma (me-
dian, 576 ppm),mycosis fungoides (median, 480 ppm),malignant
melanoma (median, 446 ppm), and breast cancer (median, 373
ppm) (Fig. 1, black bars; see also Table S2 in the supplemental
FIG 1 Relative P. acnes levels in enriched (black bars) and shotgun-sequenced (gray bars) samples having a median P. acnes proportion of 1 ppm. The
proportions of unique P. acnes reads (in parts permillion) organized according to tissue type are shown on a logarithmic scale. The error bars indicate 1 standard
deviation. BCC, basal cell carcinoma; Subcut., subcutaneous.
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material). The proportions of P. acnes reads detected in the re-
maining enriched samples were below 100 ppm (median, 0.8 to 89
ppm). P. acnes reads were also detected in nontemplate control
samples containing PBS run in parallel with the enriched samples
(n 19). In these samples, the relative proportion ofP. acnes reads
was high (median, 10,377 ppm) (see Discussion).
Total DNA extracted from 107 samples was subjected to shot-
gun sequencing (Table 1). Only samples from patients with basal
cell carcinoma (median, 3.9 ppm), malignant melanoma (me-
dian, 1.2 ppm), and breast cancer (median, 1.1 ppm) contained
relativeP. acnes levels above 1 ppm (Fig. 1, gray bars; see also Table
S2 in the supplemental material). The fold increase in the median
number of P. acnes reads (parts per million) in enriched samples
relative to the number in shotgun-sequenced samples ranged
from 35 in colon cancer biopsy specimens (12 versus 0.3 ppm)
to1,000 in samples from patients with mycosis fungoides (480
versus 0.5 ppm). The blood samples contained the lowest relative
P. acnes levels of all samples included in this study (median, 0.05
ppm).
Distribution of P. acnes strains. To assess the P. acnes strains
and the phylogenetic groups present in our samples, we analyzed
the distribution of reads mapping to the 97 P. acnes genomes used
in our analysis. Only reads mapping unambiguously to one P.
acnes strain were included in the analysis. Using this criterion, an
average of 8.6% of the P. acnes reads were included in the analysis
(see Table S3 in the supplemental material); however, with this
approach we ensured a high stringency when assigning the reads.
Figure 2 shows the relative abundance of strains for each sample.
The phylogenetic type is indicated next to the individual strain
names. For 20 of the strains included, the phylogenetic type was
not determined, and these are designated unknown (Unkn.).
Overall, two strains predominated across samples for both en-
riched and shotgun-sequenced samples (Table 2; see also Table S4
FIG 2 Relative distribution of P. acnes strains in the individual samples. The y axis shows the percentage accounted for by each strain, and each vertical line
represents a sample. The bottom horizontal lines indicate enriched or shotgun-sequenced samples, and the bottom vertical ticks delimit the sample categories.
The phylogenetic type of the P. acnes strains is indicated next to the strain name in the key on the right. The strains mentioned in the main text are highlighted
in bold. NTC, nontemplate control; Unkn., unknown.
TABLE 2 Prevalence of the 20 most frequently detected P. acnes strains
in samples investigated by microbial enrichment, shotgun sequencing,
and all samples combined
Strain
Prevalence (%) in:
All samples Microbial enrichment Shotgun sequencing
119_PAVI 82 83 64
SK182B-JCVI 78 81 60
HL025PA1 56 62 36
JCM 18920 45 66 6
HL050PA2 44 52 23
HL001PA1 34 51 4
HL411PA1 32 26 36
C1 31 46 3
HL110PA4 29 14 46
ATCC 6919 27 32 14
JCM 18909 26 37 4
HL082PA2 24 35
J165 24 22 22
HL201PA1 20 29
HL110PA1 19 27
HL030PA1 16 21
SK187 15 22
HL099PA1 15 21
HL078PA1 12 18
J139 11 15 4
HL087PA2 15
KPA171202 14
HL056PA1 7
HL110PA3 6
HL025PA2 4
HL046PA2 3
HL074PA1 3
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in the supplemental material), namely, strains 119_PAVI and
SK182B-JCVI (both of unknown phylogenetic type). Strains
HL025PA1 and HL050PA2 (type IA1 and type II, respectively)
were also among the 10 most abundant strains detected by both
methods. Certain strains, such as JCM 18920 (unknown type),
HL001PA1 (type II), and C1 (type IA1), were mainly detected in
enriched samples, while other strains, such as HL110PA4 (type II)
and HL411PA1 (unknown type), were mainly detected in shot-
gun-sequenced samples.
Generally, greater strain diversity was seen in enriched tissue
samples (Fig. 2, left, indicated by the striated pattern seen for those
samples; see also Fig. S1 in the supplemental material) than in
shotgun-sequenced samples, ranging from an average of 10 differ-
ent strains in samples from patients with testicular cancer to an
average of 29 different strains in samples from patients with my-
cosis fungoides. The remaining samples contained an average of 2
to 9 different strains.
Coverage of the P. acnes genome. To evaluate the genomic
coverage of P. acnes, nonhuman sequencing reads mapping to the
12 full genomes were presented using the Circos program (see Fig.
S2 at http://www.cbs.dtu.dk/txema/Supplementary/propioni
_web/index.html). The plots show evenly distributed sequencing
reads leading to almost full coverage of the P. acnes genome in
some samples, whereas more sporadic coverage was seen in sam-
ples containing lower P. acnes levels. A disproportionately high
sequencing depth was seen in two or three regions, depending on
which reference genome was used for mapping, corresponding to
the regions containing the genes encoding the rRNAs. The high
depth of sequencing could be a result of reads originating from
bacteria other than P. acnes mapping to the rRNA regions as a
result of high sequence similarity between different bacterial
rRNAs, as the algorithm used for generating the plots allows some
mismatches, unlike the more stringent mapping algorithm used
for quantification. To investigate if an excess of reads in the rRNA
regions impacted the quantitative proportions of P. acnes, we re-
analyzed these data by excluding reads mapping to the rRNA re-
gions. For themajority of the samples, the reanalyzed values of the
median relative levels of unique P. acnes reads were 1% lower
than the values presented above, except for some sample types
containing very low numbers of P. acnes reads (see Table S2 in the
supplemental material). These results indicate that an excess of
reads mapping to rRNA regions generally was not found in our
quantification analysis.
DISCUSSION
Duringmetagenomic analysis of next-generation sequencing data
from patient samples, we identified considerable amounts of ge-
netic material from the bacterium P. acnes. P. acnes is known to
contaminate human samples, and this initial discovery therefore
prompted us to investigate the abundance of P. acnes in metag-
enomic data from a range of different human clinical samples. In
the present study, we investigated the proportions ofP. acnesDNA
in data from samples subjected to enrichment for intact microbes
and from samples subjected to shotgun sequencing of the total
pool of DNA. We detected the highest relative levels of P. acnes in
samples subjected to enrichment, with relative P. acnes levels be-
ing the highest in skin tissue-derived samples and breast cancer
biopsy specimens (Fig. 1). Basal cell carcinoma samples contained
the highest P. acnes levels among the shotgun-sequenced samples,
while most other shotgun-sequenced samples as well as enriched
samples from patients with BCP-ALL contained P. acnes at levels
below 1 ppm (see Table S2 in the supplemental material).
Prior to surgical procedures or penetration of the skin for sam-
pling of blood, the skin is routinely sterilized using antiseptics.
However, antiseptic preparation of the skin does not kill all bac-
teria or affect bacteria present in the deeper layers of the skin (26,
27), and bacteria from surrounding areas of the skin may rapidly
recolonize the antiseptically treated areas (28, 29). Moreover, an-
tiseptics do not remove extracellular bacterial DNApresent on the
skin. Therefore, detection of P. acnes in skin tissue samples is not
unexpected. As the breast tissue lies just beneath the subcutaneous
adipose tissue in an area of the skin rich in P. acnes, contamination
from the skin during surgery is conceivable.
In our study, microbial enrichment was achieved by reducing
the amount of host endogenous DNA by centrifugation and fil-
tration followed by nuclease treatment of fluid samples or tissue
homogenates. This procedure is widely used for enrichment of
intact viral particles in virus discovery studies (30–33) and results
in an increase in the amount of intact viral nucleic acids relative to
the amount of host nucleic acids (34).We did not culture bacteria
from the samples, and therefore, we do not know if the detected
bacterial DNA originated from live bacteria capable of forming
colonies. As the DNA of live bacteria is protected from degrada-
tion by DNases (35, 36), the up to 1,000-fold increase in the
median proportion of P. acnes reads achieved upon enrichment
could suggest that the P. acnes DNA detected in our samples at
least partially originated from live bacteria.
Over the years, P. acnes has been detected in samples from
patients with diverse diseases, which has led to its proposed asso-
ciation with several conditions. Among these, P. acnes has been
implicated in the pathogenesis of acne vulgaris, although its role in
this condition is still debated (37). Other diseases for which the
bacterium is proposed to play a role are sarcoidosis (9), diverse
spine conditions (15–17), SAPHO syndrome (8), aortic aneu-
rysms (18), and prostate cancer (19). Common to these studies is
that detection of P. acnes is based on culture, PCR, or a combina-
tion of the two. In most of the studies, roughly half of the samples
are positive, and the identified bacterium is P. acnes in about half
of the cases. Besides the proposed role in certain diseases and
syndromes, P. acnes is considered a contaminant of blood prod-
ucts (11, 38), surgical wounds (12, 39), and heart valve tissue
cultures used in the diagnosis of infection during valve replace-
ment surgery (10). The fact thatP. acnes is often detected at similar
frequencies in surgical wounds and samples from patients with
various diseases could imply that the detection of P. acnes is inci-
dental as a result of its widespread presence. Studies investigating
the role of P. acnes or other ubiquitous bacteria in infections or
diseases should therefore be designed to allow researchers to dis-
tinguish between contamination and true infection. Approaches
suggested to help distinguish between these include the perfor-
mance of multiple cultures (11), histopathological analysis (7),
distinguishing of single bacterial cells from biofilm-related infec-
tions by immunofluorescence microscopy (12), and investigation
of the ability of P. acnes isolates to form biofilm (40). The inva-
siveness of P. acnes isolates may also hint to a possible disease-
causing role of P. acnes in some cases (41). MLST schemes have
revealed three major phylogenetic groups of P. acnes, types I, II,
and III (42, 43), with type I being further divided into types IA1,
IA2, IB, and IC. Clustering analysis found acne vulgaris to be pre-
dominantly associated with certain clonal complexes within type
Mollerup et al.
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IA1, while types IB and II were more frequently recovered from
soft tissue and retrievedmedical devices. CertainP. acnes sequence
types from types II and III were recovered only from healthy skin
(44).
In our samples, recurring P. acnes strains predominated across
sample types, including in the nontemplate controls (see Table S4
in the supplementalmaterial). Twoof these strainswere also ubiq-
uitously detected in skin microbiomes (3). These findings could
suggest that some strains are widespread among individuals or
that they arise from reagent or lab contamination, as P. acnes or
propionibacteria are well-known contaminants of next-genera-
tion sequencing data (45–47). Our nontemplate controls contain-
ing PBS run in parallel with the enriched samples contained high
relative levels of P. acnes. This could occur as a result of cross-
contamination during sample processing, contamination from
lab personnel or the reagents used, or bleeding over from libraries
with high P. acnes levels sequenced on the same lanes of the flow
cell (34, 48). With the exception of two, all the nontemplate con-
trol libraries contained DNA at levels below the detection limit of
both the Qubit and Bioanalyzer instruments (data not shown),
but the libraries were nevertheless sequenced. Comparison of the
nontemplate control data sets to the data sets for the other en-
riched samples showed that the controls contained an average of
12% human reads, while the biological samples contained an av-
erage of 91% human reads (see Table S2 in the supplemental ma-
terial). This dissimilar composition of the data sets suggests that
the sequence reads in the controls, including theP. acnes reads, did
not mainly originate from cross contamination or bleeding over.
Studies investigating contamination in next-generation sequenc-
ing data show thatmore dilute samples contain higher fractions of
contaminating reads (46, 47) and that negative controls contain
reads mapping to a variety of bacterial genera, including propi-
onibacteria (47). This could be explained by the more extensive
PCR amplification of contaminant templates from samples con-
taining nearly no DNA than of the same amount of contaminant
templates from complex samples containing human DNA as well
competing for the same quantity of primers and other PCR re-
agents. Considering this skewed amplification and the circum-
stance that the biological data sets are diluted with a large amount
of endogenous human reads, the relative level of P. acnes reads in
the controls becomes less astounding. The detection of P. acnes in
the controls can thus be interpreted as further evidence of how
easily samples are contaminated with this ubiquitous bacterium,
regardless of the source.
We believe that the high relative P. acnes levels detected, par-
ticularly in enriched skin tissue and breast cancer biopsy samples,
reflect patient-derived contamination. Similar patterns showing
traces of P. acnes inmost sample types and higher levels in samples
from P. acnes-rich body sites have been seen in other microbiome
studies (49). Our hypothesis is supported by the high diversity of
P. acnes strains seen in these samples compared to the lowdiversity
seen in other samples, including the controls (see Fig. S1 in the
supplemental material). The low strain diversity in the controls
supports the hypothesis that overamplification occurs in these
samples. More adequate negative controls for P. acnes levels in
our study were the blood samples from colon cancer patients, as
these are, in principle, sterile samples containing high levels of
endogenous DNA. In these samples, we detected practically no P.
acnes reads (median, 5 in absolute numbers, or 0.05 ppm; see
Table S2 in the supplemental material).
Considering our findings, it is possible that contamination de-
rived from the patient, the hospital personnel, or the lab personnel
or that arises during sample processing and analysis contributes to
the presence of P. acnesDNA in samples processed in clinical and
molecular laboratories. The risk of contamination should there-
fore be considered carefully when interpreting molecular and se-
quencing data showing the presence of P. acnes, and negative con-
trols should always be included. Typing of P. acnes can be a
relevant tool when tracing the origin of P. acnes, but it does not
necessarily provide clinically relevant information, as presumed
cutaneous P. acnes strains are readily detected in diverse sample
types. Efforts should be made to exclude the possibility that P.
acnes originates from contamination and, importantly, to prove
the causal relationship between this bacterium and the disease in
question.
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